
zzso risk in a patient with obesity hypertension increases with the extent of risk factor zzso It is therefore important to determine the global risk of a patient with hypertension rather than to focus solely on blood zzso Every zzso should be screened for other than blood pressure risk factors, target organ damage and zzso diseases or accompanying clinical zzso Assessment of blood pressure and target organ damage might be more difficult in obese zzso than in zzso zzso zzso lifestyle interventions can reduce weight, and decrease blood pressure and cardiovascular risk in obese zzso zzso Current guidelines do not provide specific recommendation for pharmacological management of the zzso patients with zzso Recent trials have consistently shown that therapy involving zzso and zzso may induce more zzso diabetes compared with other combination zzso Several lines of evidence suggest that zzso agents that block the zzso system may be especially beneficial in treating obese zzso zzso zzso management in obese individuals is complicated by poorer response to treatment, and the increased need for multiple zzso It is important to consider zzso sleep zzso in the differential diagnosis of zzso patients who respond poorly to combination therapy with zzso zzso 

